PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAC8. A total of 18 filers reported holding PDL BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $292,000 | – | 237,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 20,750,000 | $25,781,000 | 3.35% |
| Sage Capital Management, LLC | 2,500,000 | $3,092,000 | 3.23% |
| WHITEBOX ADVISORS LLC | 24,874,000 | $30,844,000 | 1.62% |
| Castle Creek Arbitrage, LLC | 17,350,000 | $21,507,000 | 0.98% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 4,598,000 | $5,673,000 | 0.52% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,690,000 | $19,386,000 | 0.50% |
| AMUNDI ASSET MANAGEMENT US, INC. | 25,195,000 | $31,084,000 | 0.13% |
| Cutler Capital Management, LLC | 237,000 | $292,000 | 0.13% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,500,000 | $4,371,000 | 0.13% |
| LAZARD ASSET MANAGEMENT LLC | 14,457,000 | $17,836,000 | 0.04% |